bpc-157 randomized controlled trial humans as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Peptide Therapy for Pain Management

Even if BPC-157 survives gastric acid, pepsin and pancreatic proteases remain active in the duodenum and small intestine at physiological pH and will hydrolyze unprotected peptide bonds

AOD-9604, a synthetic fragment derived from the C-terminal region of human growth hormone, has been subjected to extensive clinical evaluation involving over 900 participants across six randomized controlled trials

Each product comes with a Certificate of Analysis (COA) documenting the exact purity levels

Potential Risks Typical side effects are local injection-site pain, redness, mild swelling, headaches, and light-headedness

Notably, the panel currently has several vacancies, which Kennedy could fill with new appointments before the July meeting, a detail that has drawn concern from regulatory oversight advocates